Once valued at $10B, bluebird bio sold to private equity firms for $29M – FiercePharma

  1. Once valued at $10B, bluebird bio sold to private equity firms for $29M  FiercePharma
  2. Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker  CNBC
  3. What’s Going On With Gene Therapy Company Bluebird Bio Stock Today?  Yahoo Finance
  4. bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital  Business Wire
  5. Bluebird, Facing Cash Crunch, To Go Private In Deal Valued at $30M  BioSpace